Atlas Trials

Safety and Efficacy of Anti-BCMA-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM

Clinical trial NCT06515262 · RECRUITING

Trial details

NCT number
NCT06515262
Sponsor
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Relapsed/Refractory Multiple Myeloma
Start date
2024-07-01
Primary completion
2026-11-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.